Hangzhou Zhongmei Huadong Pharmaceutical Co: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Endocrinology, Obesity, and Metabolic

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaEndocrinology, Obesity, and Metabolic
Active Phase II & III Studies16 active (10 recruiting now)
Total Tracked Studies (2018 to 2026)24
Completed vs Early-Stopped Studies6 completed / 0 stopped (0.0% stop rate)
Median Closed Enrollment339 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk